Jennifer A. Sealey-Voyksner
Director Técnico/Científico/I+D en ENTERO THERAPEUTICS, INC. .
Perfil
Jennifer A.
Sealey-Voyksner is the founder of ImmunogenX, Inc., a company founded in 2013.
She held the title of Director & Chief Scientific Officer from 2013 to 2024.
Currently, Dr. Sealey-Voyksner is the Vice President-Research & Development at First Wave Biopharma, Inc., starting in 2024.
Cargos activos de Jennifer A. Sealey-Voyksner
| Empresas | Cargo | Inicio |
|---|---|---|
| ENTERO THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 13/03/2024 |
Antiguos cargos conocidos de Jennifer A. Sealey-Voyksner.
| Empresas | Cargo | Fin |
|---|---|---|
ImmunogenX LLC
 ImmunogenX LLC BiotechnologyHealth Technology ImmunogenX LLC develops diagnosis and treatment for autoimmune and gastrointestinal diseases. It focuses on therapy, disease management, and food safety. The company was founded by Jack A. Syage and Jennifer A. Sealey-Voyksner in 2013 and is headquartered in Newport Beach, CA. | Fundador | 13/03/2024 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ENTERO THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
ImmunogenX LLC
ImmunogenX LLC BiotechnologyHealth Technology ImmunogenX LLC develops diagnosis and treatment for autoimmune and gastrointestinal diseases. It focuses on therapy, disease management, and food safety. The company was founded by Jack A. Syage and Jennifer A. Sealey-Voyksner in 2013 and is headquartered in Newport Beach, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Jennifer A. Sealey-Voyksner
